CRT 2024

LIFETIME MANAGEMENT POST-TAVR AND VALVE IN VALVE

Moderator(s)

• 

  Mirvat Alasnag, MD, FSCAI, FACP, FACC, FSCCT

  Catheterization Laboratory Director & Deputy Head of Cardiology
  King Fahd Armed Forces Hospital
  Jeddah, Makkah, Saudi Arabia

  No relationships to disclose
• 

  Stanley J. Chetcuti, MD

  Co-Director Structural Heart Program/ Director Cardiac Catheterization Laboratory
  University of Michigan
  Ann Arbor , Michigan, United States

  Disclosure(s): Abbott Vascular: Advisor or Review Panel Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing); BSCI: Advisor (Ongoing), Clinical Trial Investigator (Ongoing); Edwards Lifesciences LLC: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing); MDT: Advisor (Ongoing), Advisor or Review Panel Member (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant/Advisory Board (Ongoing)
• 

  Isaac George, MD

  Associate Professor of Surgery (in Medicine)
  New York Presbyterian - Columbia University Medical Center
  New York, New York, United States

  Disclosure information not submitted.
• 

  Kendra J. Grubb, MD

  Surgical Director, Structural Heart and Valve Center
  Emory University
  Atlanta, Georgia, United States

  No relationships to disclose